Annexon (ANNX) Accumulated Expenses (2019 - 2026)
Annexon's (ANNX) quarterly Accumulated Expenses came in at $2.3 million in Q1 2026, down 89.0% year-on-year from $20.5 million in Q1 2025, and down 90.91% quarter-over-quarter from $24.8 million in Q4 2025.
Annexon (ANNX) Accumulated Expenses (2019 - 2026) Analysis & Trends
Annexon's Accumulated Expenses history runs 8 years deep, the most recent figure standing at $2.3 million for Q1 2026.
- On a quarterly basis, Accumulated Expenses fell 89.0% year-over-year to $2.3 million in Q1 2026; TTM through Mar 2026 was $2.3 million, a 89.0% decrease from a year earlier, with the FY2025 full-year figure at $24.8 million, up 41.11% from the prior year.
- Accumulated Expenses slipped to $2.3 million in Q1 2026 per ANNX's latest filing, from $24.8 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $26.4 million in Q2 2025 and bottomed at $1.4 million in Q1 2022.
- The 5-year median for Accumulated Expenses is $8.1 million (2022), against an average of $10.4 million.
- Across the five-year window, Accumulated Expenses surged 1147.35% in 2025 and plunged 89.0% in 2026, its largest moves.
- Year by year, Accumulated Expenses stood at $5.3 million in 2022, then gained by 5.81% to $5.6 million in 2023, then soared by 213.32% to $17.6 million in 2024, then soared by 41.11% to $24.8 million in 2025, then slumped by 90.91% to $2.3 million in 2026.
- Per Business Quant, the three latest ANNX Accumulated Expenses figures stand at $2.3 million (Q1 2026), $24.8 million (Q4 2025), and $22.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Annexon | 1.03 Bn | 804.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.25 Mn |
| Dec 31, 2025 | 24.79 Mn |
| Sep 30, 2025 | 22.54 Mn |
| Jun 30, 2025 | 26.41 Mn |
| Mar 31, 2025 | 20.49 Mn |
| Dec 31, 2024 | 17.57 Mn |
| Sep 30, 2024 | 10.86 Mn |
| Jun 30, 2024 | 10.66 Mn |
| Mar 31, 2024 | 1.64 Mn |
| Dec 31, 2023 | 5.61 Mn |
| Sep 30, 2023 | 4.86 Mn |
| Jun 30, 2023 | 8.95 Mn |
| Mar 31, 2023 | 2.05 Mn |
| Dec 31, 2022 | 5.30 Mn |
| Sep 30, 2022 | 3.79 Mn |
| Jun 30, 2022 | 8.06 Mn |
| Mar 31, 2022 | 1.38 Mn |
| Dec 31, 2021 | 9.25 Mn |
| Sep 30, 2021 | 7.06 Mn |
| Jun 30, 2021 | 5.85 Mn |